AICDA and B-cell non-Hodgkin lymphoma: Thus, supra-physiological expression of AID in R26+/AID mice did not impact on the overall mouse survival or the incidence of B cell lymphomas, regardless of the onset of expression or the absence of p53 tumor suppressor.